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Introduction: Stromal-epithelial interactions play a fundamental role in tissue homeostasis, controlling cell
proliferation and differentiation. Not surprisingly, aberrant stromal-epithelial interactions contribute to malignancies.
Studies of the cellular and molecular mechanisms underlying these interactions require ex vivo experimental model
systems that recapitulate the complexity of human tissue without compromising the differentiation and proliferation
potentials of human primary cells.
Methods: We isolated and characterized human breast epithelial and mesenchymal precursors from reduction
mammoplasty tissue and tagged them with lentiviral vectors. We assembled heterotypic co-cultures and compared
mesenchymal and epithelial cells to cells in corresponding monocultures by analyzing growth, differentiation
potentials, and gene expression profiles.
Results: We show that heterotypic culture of non-immortalized human primary breast epithelial and mesenchymal
precursors maintains their proliferation and differentiation potentials and constrains their growth. We further describe
the gene expression profiles of stromal and epithelial cells in co-cultures and monocultures and show increased
expression of the tumor growth factor beta (TGFβ) family member inhibin beta A (INHBA) in mesenchymal cells grown
as co-cultures compared with monocultures. Notably, overexpression of INHBA in mesenchymal cells increases colony
formation potential of epithelial cells, suggesting that it contributes to the dynamic reciprocity between breast
mesenchymal and epithelial cells.
Conclusions: The described heterotypic co-culture system will prove useful for further characterization of the
molecular mechanisms mediating interactions between human normal or neoplastic breast epithelial cells and the
stroma, and will provide a framework to test the relevance of the ever-increasing number of oncogenomic alterations
identified in human breast cancer.Introduction
Breast cancer is a progressive and heterogeneous disease
that arises in the epithelial cells of glands. Factors con-
tributing to the progression and heterogeneity of breast
cancer include the differentiation state of the cancer cell
of origin, the number and nature of the transforming
events, and microenvironmental cues [1-5]. In the pres-
ence of the same transforming events, the differentiation
state of the cells used for modeling breast cancer may* Correspondence: Bentires@fmi.ch
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unless otherwise stated.still influence the tumorigenicity, histology and meta-
static potential of the resulting tumors [1]. Hence, it is
essential to consider the cell hierarchy of the human
breast and to control the differentiation states of cells
used to model and study breast cancer.
The breast epithelium is embedded in stromal tissue
consisting of extracellular matrix (ECM), mesenchymal,
endothelial and immune cells. The epithelium of the
mouse and human mammary gland is organized hier-
archically and encompasses undifferentiated stem/pro-
genitor cells and differentiated luminal epithelial and
basal myoepithelial cells [6-11]. Stemness is a dynamic
property tightly controlled by the stem cell niche, whichd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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specialized stromal and epithelial cell types as well as a
defined ECM [12-16]. The niche regulates tissue ho-
meostasis by controlling mammary stem cell quiescence
and activation under the influence of systemic and local
cues [17-19].
In mice, bone marrow mesenchymal stem cells (MSCs)
and hematopoietic stem cells were shown to interact
and form a bone marrow niche [20]. MSCs were disco-
vered originally in the bone marrow but later described
in many tissues [21,22]. They display a vast differenti-
ation potential, giving rise to mesodermal and non-
mesodermal cell lineages such as osteocytes, adipocytes,
chondrocytes, myocytes, cardiomyocytes, fibroblasts,
myofibroblasts, endothelial cells, and neurons [23-25].
Epithelial-mesenchymal interaction has been shown
to contribute to mouse mammary tissue homeostasis
[26-29]. In humans, the results of morphological stu-
dies of embryos have suggested a role for epithelial-
mesenchymal interactions in breast development [30].
Whether MSCs and/or their progeny contribute to the
maintenance of human undifferentiated breast cells re-
mains unknown.
Gene expression profiling and genome-wide sequen-
cing of human breast tumors has revealed a multitude of
alterations [31-33]. There is an urgent need for physiolo-
gically relevant ex vivo culture systems based on primary
breast cells in which the significance of identified al-
terations can be tested. Such culture systems should
recapitulate features of human breast such as cellular
composition and differentiation states [34,35].
Here we describe ex vivo cell culture conditions that
allow the maintenance and propagation of human breast-
derived primary epithelial and mesenchymal cells sim-
ultaneously. Co-culture of primary mesenchymal and
epithelial precursor cells on coated meshes allows long-
term maintenance of the differentiation potentials of
human breast epithelial and mesenchymal precursors.
Moreover, breast mesenchymal precursor cells constrain
the growth and spreading of primary epithelial cells in het-
erotypic cultures. We further describe the gene expression
profiles of stromal and epithelial cells in co-cultures and
monocultures and show that mesenchymal inhibin beta
A (INHBA) increases the colony formation potential
of breast epithelial cells.
Material and methods
Cell culture
Reduction mammoplasty tissue was obtained with ap-
propriate informed consent from the patients and fresh
samples used to isolate primary human breast epithelial
cells (PHBECs) and human adipose tissue-derived mes-
enchymal stem cells (hAMSCs) using modifications of
published protocols [36-39]. Approval for the study wasgranted by the Ethic Commission Beider Basel (EKBB). In
brief, adipose tissue was separated from epithelial breast tis-
sue by gentle scraping with sterile scalpels. Tissue that con-
tained fine epithelial filaments or strongly vascularized
tissue was discarded and only yellow tissue was processed
further. The selected tissue was washed twice with equal
volumes of PBS and 100-μm cell strainers (BD, Falcon)
were used to drain PBS. The tissue was chopped with
sterile scalpels until a homogenous, almost liquid mass
was obtained. The fat tissue was digested for 2 h with
digestion medium comprising DMEM/F12, 15 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1 ×
penicillin/streptomycin, insulin (10 μg/mL), hydrocortisone
(0.5 μg/mL), and collagenase type A from Clostridium histo-
lyticum (Roche Diagnostics) (1 mg/mL, >0.15 U/mg) at 37°
C on a rotating wheel. The solution was centrifuged for 5
minutes at 192 g and the supernatant discarded. Resulting
pellets containing erythrocytes were incubated for 10 mi-
nutes in red blood cell lysis buffer. The solution was then fil-
tered with 70-μm cell strainers (BD, Falcon) in new tubes
and equal volumes of MSCM (DMEM/F12 supplemented
with 15 mM HEPES, 10% fetal calf serum, 1 nM 17-β-
estradiol, and 1 × penicillin/streptomycin). Cells were then
centrifuged for 5 minutes at 192 g and washed twice with
MSCM before re-suspension in MSCM and filtering
through 40-μm cell strainers (BD, Falcon) to remove large
debris. Cells were counted, plated at densities of 500 to
1,000 cells per 10 cm2 and incubated at 37°C in a humidified
5% CO2/O2 controlled incubator. After 24 h, media was re-
moved, the cells washed with PBS, and fresh medium added
to expand cells for 14 days before freezing. Breast epithelial
cells were cultured in mammary epithelial cell growth
medium (MEGM) [40], human mammosphere medium
(HMM) [41] or M5 medium comprising 50% M199
medium (ANIMED/Bioconcept), 50% F12 (SIGMA) supple-
mented with 20 ng/mL epidermal growth factor (EGF)
(PeproTech DE), 1 × B-27 (Invitrogen/GIBCO), 1 nM 17-β-
estradiol, 57 μM β-mercaptoethanol, 15 mM Hepes
(SIGMA) and 1 × penicillin/streptomycin (Invitrogen/
GIBCO). M5 was used for all experiments unless stated
otherwise. Uncoated tissue culture plastic (BD, Falcon Pri-
maria) was used for monolayer colony formation and differ-
entiation assays of PHBECs. From 500 to 2,000 cells were
seeded per well in 6-well plates and grown in M5 medium
for 7 to 10 days prior to fixation. A published method [40]
was adapted to test the potential for differentiation into β-
casein-secreting alveolar cell lineages (lactogenesis assay).
Briefly, PHBECs were seeded as for the colony formation
assay and grown in M5 medium for 10 days. The colonies
were then overlaid with matrigel and incubated for 2 days
before addition of the differentiation medium (M5 medium
supplemented with hydrocortisone 1 μg/mL, insulin 5 μg/
mL, and recombinant human prolactin 1 μg/mL, all from
SIGMA). Half of the medium was replaced by fresh
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fixed 7 days after exposure to differentiation medium. All
cells were cultured at 37°C in a humidified 5% CO2, 5% O2
controlled incubator.
Lentivirus infections
CFP from pECFP (Clontech) and VENUS NLS [42] were
cloned into pRRLhPGK.GFP.SIN18 [43] using BamHI
and BsrGI restriction sites and lentiviruses were pro-
duced by calcium phosphate transfection of 293 T cells
as described [43]. The titer of each lentiviral batch was
determined on PHBECs. hAMSCs grown on Primaria
plates were infected for 6 h in the first passage in the
presence of hexamethrine bromide (8 μg/mL, SIGMA)
and the cells were selected 48 h later with 0.8 μg/mL
puromycin (Invitrogen) for 5 days. Freshly dissociated
PHBECs were infected in suspension for 6 h in the pres-
ence of hexamethrine bromide (8 μg/mL) and then
grown in ultra-low attachment (ULA) dishes (Corning)
for 6 days. All infections were performed at a multipli-
city of infection of 20 viral particles per cell. Selection
with 0.8 μg/ml puromycin was applied 48 h after infec-
tion. The spheres formed were dissociated and the re-
sulting single cells aggregated.
Ex vivo niche cultures
Cell strainers (40 μm; BD, Falcon) were coated with a
mixture of 100 μg/mL rat tail collagen (Roche) and 10%
(v/v) Matrigel (BD). Rat tail collagen (Roche) was re-
constituted with sterile 0.2% acetic acid (v/v) for at least
6 h at 4°C and then diluted to obtain a final concentra-
tion of 100 μg/ml collagen in M199/F12 (50% M199
(ANIMED/Bioconcept), 50% F12 (SIGMA) plus 15 mM
HEPES (Invitrogen/GIBCO)). The mixture was briefly
vortexed and chilled on ice for 10 minutes. Matrigel
(10% v/v) (BD) was added and the mixture vortexed for
10 s and chilled on ice for 10 minutes. In the meantime,
the noses of 40-μm cell strainers were cut with sterile
curved surgical tissue scissors and the strainers placed in
6-well tissue culture plates (Corning). Collagen/Matrigel
mixture (1.5 ml) was slowly and carefully added to the
center on top of the nylon mesh. The strainers were in-
cubated at 37°C for 30 minutes before being removed
from the plates and turned upside down to discard spare
collagen/Matrigel mixture. The coated strainers were
then carefully transferred to fresh 6-well plates for wa-
shing with 3 mL of pre-warmed (37°C) M199/F12. After
this washing step, the coated strainers were transferred
into ULA 6-well plates (Corning) containing 3 mL of
pre-warmed (37°C) M5 medium. The plates were incu-
bated at 37°C in a humidified 5% CO2, 5% O2 controlled
incubator until cell aggregates were added. Equal num-
bers of hAMSCs and PHBECs were aggregated at den-
sities of 100,000 cells per mL of M5 medium in ULAdishes. After 4 to 6 days, the aggregates were collected
by mild centrifugation (50 g for 30 s) and seeded on
coated 40-μm cell strainers; 25% (v/v) of fresh medium
was added every 2 to 3 days and replaced completely
every 8 to 9 days.
Dissociation of ex vivo niche cultures
Cells were dissociated with HyQtase (HyClone, Thermo
Scientific) for 20 minutes on a rotating wheel at 37°C.
Subsequent pipetting for 5 minutes and filtering through
40-μm cell strainers (Falcon) yielded single cells that
could be used for cell sorting, colony formation and dif-
ferentiation assays.
Antibodies and immunochemistry
Only cells without fluorescent protein tags were stained.
Cells were fixed with ice-cold methanol/acetone (50/50
v/v) for 10 minutes at room temperature. The cells were
incubated at 4°C overnight with the following prima-
ry antibodies: keratin 14 (RB-9020, 1:4,000), keratin 18
(MS-142, 1:2,000), keratin 19 (MS-198 1:1,000), β-casein
(MS-935 1:1,000), Ki67 (RB-1510, 1:500) (Thermo Scien-
tific, Stehelin), p63 (MS-1081, 1:200) (Thermo Scientific),
e-cadherin (610181, 36/Ecad, 1:1,000) (BD Bioscience,),
EpCAM (Clone 9C4, 1:100) (BioLegend), or keratin 8/18
(GP11, 1:500) (Fitzgerald). Goat anti-mouse, goat anti-
rabbit or goat anti-guinea pig secondary antibodies
coupled to Alexa 488, 568 or 633 (Molecular Probes,
Invitrogen 1:500) were used for detection.
Microscopy and image analysis
For phase-contrast and fluorescence imaging of adherent
cells and floating ex vivo cultures, images were acquired
with an inverted microscope (Nikon Eclipse Ti) using a
10× lens (Nikon Plan Fluor, NA 0.3) and a Nikon Ds-Fi
camera. Immunofluorescent staining was analyzed with
an inverted Zeiss Z1 microscope using a 20× air lens
(Zeiss Plan-APOCHROME, NA 0.8) equipped with a
motorized Zeiss scanning stage. Axiovision software was
used to acquire and stitch images. For confocal micros-
copy, meshes were mounted between glass slides and
coverslips with ProLong anti-fade reagent (Invitrogen)
before analysis on an LSM-510 confocal microscope
(Zeiss) using a 20× air lens (Zeiss Plan-APOCHROME,
NA 0.8). Both Zeiss microscopes were equipped with an
Axio Cam MRC CCD (6.45 micron). The Image-J (Fiji
(64 bit)) software [44] was used for image quantifications
and three-dimensional reconstruction.
hAMSCs differentiation assays
Approximately 50,000 first-passage hAMSCs from re-
duction mammosplasties were seeded in Primaria 6-well
dishes and cultured in MSCM overnight. The medium was
then substituted with MSCM or M5 medium containing
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methylxanthine, 60 μM indomethacin and 10 nM 17-β-
estradiol (SIGMA) for adipogenic differentiation, or with
1 μM dexamethasone, 10 mM β-glycerophosphate, 100 μM
ascorbic acid 2-phosphate, and 10 nM 17-β-estradiol for
osteogenic differentiation. The cultures were maintained
for 20 days before being fixed with formalin. Adipogenic
differentiation was determined by staining with Oil red
O (0.3%; SIGMA) in isopropanol (57%) and water to
detect lipid. Staining of alkaline phosphatase activity
(SIGMAFAST BCIP, SIGMA) was carried out to assess
osteogenic differentiation.
Flow cytometry
For sorting of fluorescent cells from ex vivo cultures, the
cells were filtered with 40-μm cell strainers (Falcon) after
dissociation: 4',6-diamidino-2-phenylindole (DAPI) (0.2%,
Invitrogen) was added (1:250) 2 minutes before cell sort-
ing. Fluorescence-activated cell sorting (FACS) was per-
formed with a MoFlo cell sorter (Becton Dickinson).
Single cells were gated based on their forward and side
scatter profiles; dead cells (DAPI bright) were gated out.
For sorting of cells from normal breast tissue, orga-
noids were dissociated with HyQtase (HyClone, Thermo
Scientific) for 10 minutes at 37°C and subsequent pipet-
ting. Cells were filtered twice through 40-μm cell strainers
(Falcon) to obtain single cells; 106 cells were blocked in
M5 medium for 10 minutes at 4°C with antibodies against
human CD16 (FcRIII, Clone 3G8, 1:50) and CD32 (FcRII,
Clone FUN-2, 1:100), then washed and labeled in 100 μl
M5 medium for 20 minutes at 4°C with antibodies against
human FITC-CD49f (Clone GoH3, 1:25), PerCP/Cy5.5-
CD326 (EpCAM, Clone 9C4, 1:25), APC-CD10 (Clone
HI10a, 1:20), PE-CD31 (Clone WM59, 1:33), PE-CD45
(Clone HI30, 1:33), and PE-CD235ab (Clone HIR2, 1:33).
DAPI (0.2%, Invitrogen) was added (1:250) 2 minutes be-
fore cell sorting. Single cells were gated based on their for-
ward and side scatter profiles. Dead cells (DAPI bright)
and Lin + cells (CD31+, CD45+ and CD235+) were gated
out (see Additional file 1). All antibodies were pur-
chased from BioLegend. The cells were directly sorted
into TRIzol (Invitrogen).
Microarray profiling
Viable cells were FACS-sorted into TRIzol (Invitrogen).
RNA was extracted from 300 sorted cells with the Pico-
Pure RNA isolation kit (Arcturus) and reverse-transcribed
using 4 μM T7- (dT)24/T7-(dN)6 primer mix (Affyme-
trix) and 150 units of Superscript II reverse transcriptase
(Invitrogen). The synthesis of second-strand cDNA was
performed by mixing 4 mM dNTPs, 6 units DNA po-
lymerase I, and 0.4 units RNase H in a 20-μL reaction
volume. cRNA was produced by in vitro transcription
with a T7 RNA polymerase at 37°C for 14 h using theMEGAscript T7 kit (Ambion) as per the manufacturer's
instructions. For the second cycle, the first-strand cDNA
was synthesized using 0.2 μg random primers from 9 μL
of purified cRNA. The second-strand cDNA was pro-
duced using 10 μM T7- (dN)6 primer and 40 units DNA
polymerase at 16°C for 2 h, after which 10 units of T4
DNA polymerase (Invitrogen) was added and the incuba-
tion continued for another 10 minutes. The cDNA was
in vitro transcribed with T7 RNA polymerase at 37°C for
16 h. The single-strand cDNA was synthesized using 10
μg purified cRNA in the presence of 4 μg random primers,
0.2 M DTT, 12 mM dNTP + dUTP, and 750 units Super-
script II (Roche Diagnostics) in a total volume of 20 μL.
The cRNA was hydrolyzed with 2 units RNase H at 37°C
for 40 minutes. The sense cDNA was purified and eluted
in 28 μL elution buffer. Amplified products were purified
using the GeneChip cDNA Sample Cleanup Module
(Affymetrix) with a 6,000-g centrifugation during the
first two steps. To improve recovery from the columns,
water or elution buffer was spun into the matrix at 50 g
and left to stand for 4 minutes before a 16,000-g centri-
fugation. The quantity and purity of the cRNA and
cDNA produced during the first and second rounds
were evaluated using a NanoDrop ND-1000 spectro-
photometer (Nanodrop Technologies). The cDNA was
then fragmented by uracil DNA glycosylase and apuri-
nic/apyrimidic endonuclease 1 and biotin-labeled with
terminal deoxynucleotidyl transferase using the Gene-
Chip WT Terminal labeling kit (Affymetrix). Following
hybridization, non-specifically bound nucleotides were
removed by washing and specifically bound target de-
tected using a GeneChip Hybridization, Wash and Stain
kit and a GeneChip Fluidics Station 450 (Affymetrix).
Hybridization was carried out with 5 μg of biotinylated
target, which was incubated with a GeneChip human
Gene 1.0 ST Array (Affymetrix) at 45°C for 16 h. The ar-
rays were scanned using a GeneChip Scanner 3000 7G
(Affymetrix) and CEL files acquired using GeneChip
Command Console Software (Affymetrix). Arrays were
normalized and probeset-level expression values calcu-
lated with R/Bioconductor's (v2.14) affy package using
the rma() function [45]. Differential gene expression
was determined using linear modeling implemented in
the R/Bioconductor package limma. For general analysis,
a cutoff of linear fold change >2 and P-value <0.005 were
used. Lists of differential genes were imported into In-
genuity IPA (Ingenuity Systems, [46], content version
12710793) for pathway analysis. Gene set enrichment ana-
lysis (GSEA) was performed using the JAVA application
from the Broad Institute v2.0 [47]. GSEA and gene ontol-
ogy data mining (ontologizer [48]) were performed with
the gene lists discussed. The microarray data from this
publication have been submitted to the NCBI’s Gene Ex-
pression Omnibus [49] and are accessible (see [50,51]).
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Cells were lysed with radioimmunoprecipitation assay
(RIPA) buffer (50 mM Tris–HCl pH 8, 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) supple-
mented with 1 × protease inhibitor cocktail (Complete
Mini, Roche), 0.2 mM sodium orthovanadate, 20 mM
sodium fluoride, and 1 mM phenylmethylsulfonyl fluor-
ide (SIGMA); 25 μg of protein lysate was loaded onto
8% SDS PAGE gels. Immunoblots were performed with
antibodies against ITG11A1 (Abnova, 1:700), COL11A1
(Abcam 1:1,000), MMP13 (Thermo Scientific, 1:500),
INHBA (Abcam, 1:500), SULF1 (Abcam, 1:500), EPYC
(SIGMA, 1:2,000), TNFSF4 (BioLegend, 1:300) and ERK2
(Santa Cruz Biotechnology, 1:2,000) overnight at 4°C.
Statistical analysis
Data were tested for normal distribution and the stan-
dard two-tailed t-test or analysis of variance (ANOVA)
was applied. The Tukey-Kramer honest significant differ-
ence (HSD) test was performed to account for multiple
comparisons. Excel 2010 and JMP11 (SAS) were used
for all statistical tests. Experiments were carried out with
at least three biological replicates unless stated
otherwise.
Results
Isolation and propagation of human breast epithelial and
mesenchymal precursor cells
The human breast is composed of a network of ductal
and alveolar epithelial cells embedded in a stroma that
includes connective and fatty tissues. We isolated mes-
enchymal and epithelial breast precursor cells and de-
fined cell culture conditions that allow the maintenance
and the propagation of these precursors simultaneously
and their differentiation upon exposure to specific cues.
We adapted previously described experimental proce-
dures for the isolation of PHBECs and hAMSCs from
breast tissue [36,38]. Human breast reduction mammo-
plasty tissue samples were subjected to mechanical and
enzymatic dissociation steps to obtain single-cell suspen-
sions of epithelial and fat tissue fractions (Figure 1A). To
enrich for epithelial stem/progenitor cells while dep-
leting differentiated cells, we cultured the epithelial frac-
tion in low-density suspension conditions on ULA plates
as described previously [41]. Homogenous hAMSC cul-
tures were obtained by seeding single cells from the
breast adipose tissue fraction as low-density monolayer
cultures.
As our ultimate goal was to co-culture mesenchymal
and epithelial precursor cells, it was essential to define
cell culture conditions that allow the simultaneous growth
of both mesenchymal and epithelial precursors without
compromising their differentiation potential. To this end,
we developed a novel serum-free cell culture medium(M5) by combining the previously described HMM and
WIT media [1,41]. We maintained cultures at 5% oxygen
tension to reduce oxidative stress and to culture primary
cells in physiological conditions [52,53]. For monolayer
culture and/or differentiation assays, cells were grown on
a tissue culture surface with negatively charged oxygen-
and positively charged nitrogen-containing functional
groups (BD Primaria), which aided the attachment and
culture of primary cells [1,54,55].
We compared the differentiation potential of epithelial
cells seeded at low densities and cultured for four pas-
sages (28 days) in M5, MEGM [40] or HMM [41] cul-
ture media (see Additional file 2A). The proportions of
luminal epithelial and myoepithelial cells in these cul-
tures were monitored by immunostaining for keratin 18
(K18) and keratin 14 (K14), respectively. Epithelial cells
cultured in MEGM were mostly large, non-proliferating
and K14-positive, with 3 ± 2.5% K18-positive cells. Cells
grown in HMM were also mostly K14 positive with
6 ± 0.7% of K18-positive cells. In contrast, M5 medium
allowed more than three- and six-fold enrichment of lu-
minal cells compared with the HMM and MEGM cul-
ture media, respectively, with 19.8 ± 0.4% K18-positive
cells (see Additional file 2A). Moreover, PHBECs cul-
tured in M5 medium covered a larger area of the culture
surface than cells grown in HMM, and were smaller than
cells grown in either HMM or MEGM (see Additional
file 2A, B). Thus, we successfully defined culture con-
ditions that allow the differentiation and propagation
of both luminal and myoepithelial breast cell lineages.
M5 medium was then tested for the enrichment of
breast epithelial precursor cells. PHBECs grown in sus-
pension in M5 medium formed mammospheres [40] at
frequencies of 5.4 ± 0.9 spheres per 1,000 cells and thus
exhibited mammosphere formation frequencies similar to
breast epithelial cells grown in MEGM (5.9 ± 0.5 spheres
per 1,000 cells) or HMM medium (5.3 ± 0.6 spheres per
100 cells) (see Additional file 2C). Mammospheres grown
in M5 medium were then dissociated and their colony for-
mation capacity, a surrogate readout for progenitor/stem
cells [40], was assessed. Circa 1/200 single cells derived
from mammospheres grown in M5 medium formed
mixed colonies of luminal K19-positive and myoepithelial
K14-positive mammary epithelial cells (Figure 1B). Not-
ably, 2 to 8% of cells in the colonies were identified as K14
and K19 double-positive (yellow in merge Figure 1B), a
characteristic of putative breast stem/progenitors [56].
Triple staining for K18, K14 and the myoepithelial marker
p63 showed that 95.4% of K18-positive cells were negative
for p63, whereas 93.4% of K14 positive cells also had nu-
clear p63, thus confirming their myoepithelial nature (see
Additional file 2D). These data demonstrate that M5
medium allows the propagation of undifferentiated bi-
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Figure 1 Human breast mesenchymal and epithelial precursor cells maintain their identities in ex vivo cell culture conditions. (A)
Schematic of the experimental procedure for the isolation of mesenchymal stem cells human adipose tissue-derived mesenchymal stem cells
(hAMSCs) and primary human breast epithelial cells (PHBECs) from normal breast reduction mammoplasty tissues. Arrows: mechanical (black) and
enzymatic (gray) digestion steps. Isolated epithelial cells can be grown either as monolayer cultures (two-dimensional) or as three-dimensional
cultures. (B) Colony formation assay with single cells derived from mammospheres grown in M5 medium. Representative images of K19 (red) and
K14 (green) immunofluorescent staining of PHBEC colonies: 4',6-diamidino-2-phenylindole (DAPI)- (blue) stained nuclei. Scale bar 100 μm. (C)
Differentiation assays of mesenchymal precursor cells in M5 medium. Representative images of adipocytes and osteocytes stained with lipid
specific Oil Red O or alkaline phosphatase (AP), respectively. Scale bars 10 μm. (D) Schematics of ex vivo monoculture conditions of PHBEC (upper)
and hAMSC (lower) with representative phase-contrast images (left) and fluorescence images of PHBECs expressing enhanced green fluorescent
protein (EGFP) and hAMSCs expressing red fluorescent protein (DsRed2) after 30 days growth on an extracellular matrix (ECM)-coated mesh. Scale
bars 200 μm. (E) Representative flow cytometry dot plots showing separated DsRed2-expressing mesenchymal cells (left) and EGFP-expressing
epithelial cells (right) prior to RNA extraction and transcription profiling. (F) Gene set enrichment analysis (GSEA) with hAMSC-specific genes and
signatures of EpCAM- CD49f- CD10+ and EpCAM + breast cells isolated from normal breast tissue. hAMSC/EpCAM- CD49f- CD10+: enrichment
score (ES) = 0.87, normalized enrichment score (NES) = 3.2, false discovery rate (FDR) <0.0001, P <0.0001; hAMSC/EpCAM+: ES = −0.87, NES = −3.18,
FDR <0.0001, P <0.0001. (G) GSEA with PHBEC-specific genes and signatures of EpCAM+ and EpCAM- CD49f- CD10+ breast cells. PHBEC/EpCAM+:
ES = 0.85, NES = 3.29, FDR <0.0001, P <0.0001; PHBEC/ EpCAM- CD49f- CD10+: ES = −0.85, NES = −3.32, FDR <0.0001, P <0.0001.
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lineages when seeded in colony formation assays on a tis-
sue culture surface.
hAMSCs are usually maintained in serum-containing
mesenchymal stem cell medium [57]. To address whe-
ther hAMSC can also be maintained and differentiated in
serum-free M5 medium, we compared the differentiationpotential of hAMSCs cultured in standard mesenchymal
stem cell medium (MSCM) or M5 medium. Upon ad-
dition of adipogenic or osteogenic factors to MSCM
(see Additional file 2E) or M5 (Figure 1C), hAMSCs
differentiated into cells expressing adipocytes and os-
teocytes markers, respectively, as depicted by adipo-
cyte differentiation-specific Oil red O and osteocyte
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that isolated hAMSCs maintain their differentiation
potential when grown in serum-free M5 medium.
Altogether the data demonstrate that our methods
allow the isolation and culture of mesenchymal and epi-
thelial precursor cells from human breast tissue, as well
as the propagation and differentiation of breast epithelial
and mesenchymal precursor cells.
PHBECs and hAMSCs maintain their identity when grown
on nylon meshes submerged in M5 medium
Immortalized breast epithelial cells grown in three-
dimensional culture recapitulate features of the normal
breast [58,59]. We cultured non-immortalized human
primary breast cells for 3 weeks in monolayer, three-
dimensional Matrigel, or ULA suspension conditions but
they failed to grow after passaging. We then set out to de-
fine three-dimensional cell culture conditions that main-
tain the identities, differentiation and growth potential of
human primary epithelial and mesenchymal cells for a
long period. To be able to trace cells, we infected freshly
isolated PHBECs or hAMSCs with lentiviral constructs
bearing fluorescent proteins in suspension. PHBECs and
hAMSCs were successfully tagged with nuclear enhanced
yellow fluorescent protein (VenusNLS) or red fluorescent
protein (DsRed2), respectively (see Additional file 2F). We
then cultured tagged PHBECs or hAMSCs in suspension
to allow them to form aggregates, which were then seeded
onto nylon meshes coated with a mixture of collagen I
and laminin-rich Matrigel (Figure 1D). The aggregates set-
tled on the ECM-coated meshes and the cells invaded the
substrate (Figure 1D). To assess whether the PHBECs and
hAMSCs preserved their molecular identities when grown
as monocultures on coated meshes after prolonged ex
vivo culture, we dissociated them after 30 days ex vivo cul-
ture, used FACS to sort viable cells (Figure 1E), and ana-
lyzed the global transcriptome of these cells. Pearson
correlation matrix of the arrays revealed distinct gene
expression patterns for PHBECs and hAMSCs (see
Additional file 3A) and unsupervised hierarchical clus-
tering of expression data yielded clusters enriched in
mesenchyme- and epithelia-specific genes, respectively.
These data demonstrate the successful isolation, tagging
and maintenance of primary mesenchymal and epithe-
lial breast cells (see Additional file 3B).
To further validate the molecular identities of epithe-
lial and mesenchymal breast cells after prolonged ex vivo
culture, we set out to compare them to freshly isola-
ted breast cells. Therefore, we sorted freshly dissociated
cells from normal breast tissue organoids by FACS (see
Additional file 1) and performed gene expression analysis
of lineage-negative (Lin-) epithelial cell subpopulations
(EpCAM+ or EpCAM- CD49+) [2] as well as mesen-
chymal cell subpopulations (EpCAM- CD49f- CD10+ orEpCAM- CD49f- CD10-) [60]. We then compared the
profiles by GSEA [61,62]. We observed a very significant
overlap between the gene expression profiles of hAMSCs
from prolonged ex vivo culture and the profiles of freshly
isolated Lin- EpCAM- CD49f- CD10+ mesenchymal cells
but not with EpCAM+ epithelial cells (Figure 1F). In
addition, we found very significant overlap between the
gene expression profiles of PHBECs from prolonged ex vivo
culture and the profiles of freshly isolated Lin- EpCAM+
epithelial cells but not with EpCAM- CD49f- CD10+ mes-
enchymal cells (Figure 1G). These results further validate
the isolation methods and ex vivo culture conditions main-
taining the molecular identities of epithelial and mesenchy-
mal breast cells.
We also compared the gene-expression profiles of
PHBECs and hAMSCs (see Additional file 4A, B) to pre-
viously published profiles of dissociated breast cells
[63,64] (see Additional file 4C, D) and to the primary
breast epithelial cells (BPECs) and (HMECs) that were
shown to display two differentiation states; with HMECs
expressing two-fold more myoepithelia-specific genes
than BPECs [1] (see Additional file 4E). Notably, GSEA
revealed the gene expression signature of PHBECs cul-
tured on coated meshes to be highly correlated with the
signature of EpCAM+ epithelial cells, luminal progeni-
tor cells, and BPECs but not CD10+ myoepithelial/myo-
fibroblast cells, basal cells or HMECs, respectively (see
Additional file 4C-E) [1,63,64]. Furthermore, the gene
expression signature of hAMSCs cultured in our ex vivo
culture conditions, but not PHBECs, overlapped highly
significantly with published MSC profiles [65,66] (see
Additional file 4F, G). In summary, these data confirm
that the ex vivo cell culture conditions described here
maintain the epithelial and mesenchymal identities of
PHBECs and hAMSCs, respectively.
Breast epithelial and mesenchymal precursors constrain
growth and spreading reciprocally in heterotypic cultures
As fibroblasts and mesenchymal cells often outgrow epi-
thelial cells in cultures of primary mammary organoids
from mouse or human, we assessed the growth pro-
perties of PHBECs and hAMSCs when co-cultured in
the newly defined culture conditions. Equal numbers of
tagged PHBECs and hAMSCs were co-cultured in sus-
pension to enrich for precursors and generate hetero-
typic aggregates (see Additional file 5A). The aggregates
were seeded onto the ECM-coated nylon substratum.
Aggregates successfully attached to the substratum and
formed locally constrained clusters that enlarged pro-
gressively. These clusters consisted of epithelial cells,
mostly localized in the recesses of the meshes, covered
by mesenchymal cells (Figure 2A, B). These results
contrast with monocultures of PHBECs or hAMSCs,
which invaded the substratum and covered larger areas
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Figure 2 Heterotypic three-dimensional cultures maintain tri-potent mammary epithelial precursor cells. (A) Schematic of primary
human breast epithelial cells (PHBECs) and human adipose tissue-derived mesenchymal stem cells (hAMSCs) co-culture, phase-contrast (left) and
fluorescence images of clusters of the co-cultures grown for 30 days on an extracellular matrix (ECM)-coated mesh. Scale bar 100 μm. (B) Three-
dimensional reconstruction of 28 z-sections (0.6 μm) from confocal images of a 30-day-old co-culture of tagged-PHBECs (VenusNLS, green) and
hAMSCs (DsRed2, red) on ECM-coated mesh. Autofluorescence of nylon mesh (blue). Scale bar 10 μm. (C) Confocal images of K14- and K19-
stained 60-day-old co-cultures of untagged cells: 4',6-diamidino-2-phenylindole (DAPI)- (blue) stained nuclei. Arrows indicate double-positive
putative bi-potent epithelial progenitor cells. Scale bar 50 μm. (D) Three-dimensional reconstruction of 48 z-sections (0.4 μm) from confocal
images of K14-, K19- and DAPI-stained co-cultures (cells without fluorescent protein tags were stained). Scale bar 10 μm. Arrows indicate double-
positive cells. (E) Percentages of K14, K19 and K14/K19 double-positive cells in co-cultures. K14 versus K19, P = 0.10714; K19 versus K14K19,
P = 0.00019; K14 versus K14K19, P = 0.01444. (F) Colony formation assay. Fluorescence images of K14- and K19-stained colonies formed by single
cells derived from co-cultures of untagged PHBECs and hAMSCs. DAPI- (blue) stained nuclei. Scale bar 50 μm. (G) Percentage of colonies formed
by single cells derived from co-cultures. Total: all colonies (n >8 cells); large: large mixed colonies (n >32 cells, >4 doublings); small: small colonies
(n = 8 to 32 cells, 2 to 4 doublings). Small versus large, P = 0.46563; total versus large P = 0.13752; total versus small, P = 0.29473. (H) Lactogenesis
assay. Fluorescence images of K14-, K18- and β-casein-stained colonies derived from single cells from co-cultures grown in lactogenic differentiation
conditions. DAPI- (blue) stained nuclei. Lower right corner: 2.5-fold magnification of merged image. Scale bars 50 μm.
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not outgrow PHBECs in these co-culture conditions but
that each cell type constrains the growth and migration of
the other.
Ex vivo heterotypic culture conditions maintain
mesenchymal and breast epithelial precursor cells
The cellular and molecular composition of the human
breast environment that maintains undifferentiated hu-
man primary epithelial cells is as yet poorly defined. Wetested whether epithelial and mesenchymal precursor
cells in the co-cultures we developed might assemble an
environment able to maintain undifferentiated breast
cells in ex vivo long-term cultures.
We examined whether mature luminal cells are ge-
nerated in ex vivo heterotypic cultures. GSEA analysis
with specific signatures of co-culture and monoculture-
derived epithelial cells demonstrated that epithelial cells
maintained in ex vivo co-culture (CCE) are significantly
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Figure 3 Human adipose tissue-derived mesenchymal stem cells (hAMSCs) and primary human breast epithelial cells (PHBECs) in
co-culture restrain their spreading and their proliferation reciprocally. (A) Bar graph showing the area of the mesh covered by monocultures
of fluorescent protein-tagged hAMSCs or PHBECs, and of hAMSC/PHBEC co-cultures. Results represent means ± SD from three independent
experiments; *P <0.01, **P <0.001. (B) Fluorescent images of Ki67 immunostained ex vivo cultures (red): 4',6-diamidino-2-phenylindole (DAPI) (blue)
shows nuclei. Bar graph shows percent of Ki67-positive cells detected in each culture condition. Cells without fluorescent protein tags were
stained. Scale bars 100 μm. hAMSC versus co-culture (CC), P = 7.39E-05; PHBEC versus CC, P = 0.01312; hAMSC versus PHBEC, P = 0.00018. (C) Rep-
resentative flow cytometry dot plot showing separated red fluorescent protein (DsRed2)-expressing mesenchymal cells and enhanced green fluor-
escent protein (EGFP)-expressing epithelial cells from ex vivo co-culture prior to RNA extraction and transcription profiling. (D) Gene set
enrichment analysis (GSEA) with PHBEC-specific genes and KEGG signatures comprising cell cycle genes (MSigDB), GSEA scores: mono/CC enrich-
ment score (ES) = 0.58 normalized enrichment score (NES) = 2.38, CC/Mono ES = −0.58 NES = −2.38, false discovery rate (FDR) <0.0001, P <0.0001.
(E) GSEA with hAMSC-specific genes and KEGG signatures comprising cell cycle genes (MSigDB), GSEA scores: mono/CC ES = 0.41, NES = 1.6, CC/
Mono ES = −0.41, NES = −1.6, FDR = 0.0082, P = 0.005. (F) GSEA with PHBEC-specific genes and KEGG signatures comprising apoptosis genes
(MSigDB), GSEA scores: mono/CC ES = 0.25, NES = 0.98, CC/Mono ES = −0.25, NES = −0.98, FDR = 0.866, P = 0.476. (G) GSEA with hAMSC-specific
genes and KEGG signatures comprising apoptosis genes (MSigDB). GSEA scores: mono/CC ES = 0.31 NES = 1.17, CC/Mono ES = −0.31, NES = −1.17,
FDR = 0.487, P = 0.207.
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Additional file 5B). To further characterize the epithelial
cells maintained in the ex vivo heterotypic culture condi-
tions, we performed immunostaining and confocal mi-
croscopy of 40-day-old co-cultures. Immunostaining with
EpCAM/K18 (see Additional file 5C), e-cadherin (CDH1,
ECAD)/K18 (see Additional file 5D), and ERα/K18/K14
(see Additional file 5E) confirmed the presence of dif-
ferentiated epithelial cells in heterotypic co-cultures.
ERα staining was not detected in the co-cultures (see
Additional file 5E). Further gene expression profiling of
co-culture-derived epithelial cells showed that epithelial
genes were among the most differentially over-expressed
genes, whereas genes highly expressed in epithelial cells
from monocultures were predominantly genes involved in
the cell cycle (see Additional file 5F). FACS of dissociated
cells from 70-day-old ex vivo co-cultures and correspond-
ing monocultures stained with CD49f and EpCAMindicated the presence of different cell types in the co-
cultures, with the EpCAM + CD49f + population being
the most prominent (see Additional file 5G). We were
not able to resolve these populations in the epithelial
monocultures. These data further confirm that differ-
ent breast cell populations are maintained in our long-
term heterotypic co-cultures.
We then asked whether undifferentiated cells are also
maintained in the ex vivo culture conditions described.
Notably, immunostaining for the myoepithelial marker
K14 or the luminal marker K19 and confocal microscopy
of 60-day-old three-dimensional co-cultures of PHBECs
and hAMSCs on ECM-coated meshes revealed the pres-
ence of K14/K19 double-positive cells, previously shown
to be putative breast epithelial stem/progenitor cells [56].
K14/K19 cells were present at 1.5 ± 0.4% and located pref-
erentially in the recesses of the substratum (Figure 2C-E).
The remaining cells displayed either a myoepithelial
Duss et al. Breast Cancer Research 2014, 16:R60 Page 10 of 16
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type. Reconstitution of z-stacks of confocal frames showed
that K14/K19 cells resided in close contact with differenti-
ated epithelial cells (Figure 2D). These data suggest that
breast epithelial and mesenchymal precursors grown on
ECM-coated meshes generate an environment that main-
tains undifferentiated epithelial cells.
To address functionally the differentiation potential of
cells growing in these structures, we dissociated 60-day-
old ex vivo co-cultures and subjected the resulting single
cells to colony formation assays. Of these cells, 1.7% ±
0.4% formed colonies: 1.1% ± 0.5% formed small col-
onies, whereas 0.6 ± 0.2% formed large colonies compris-
ing luminal and myoepithelial cells (Figure 2F, G). Thus,
the three-dimensional heterotypic culture system de-
scribed here allows the assembly of structures that main-
tain bi-potent breast epithelial progenitor cells for 60
days ex vivo.
We also performed FACS of stromal cells from disso-
ciated 60-day-old ex vivo co-cultures and assessed their
differentiation potential. More than 60% of these cells
differentiated into lipid-secreting or AP-positive cells in
adipogenic or osteogenic culture conditions, respectively
(see Additional file 5H), indicating that a population of
mesenchymal precursor cells was maintained for 60 days
ex vivo.
We subsequently investigated whether the epithelial
cells in these heterotypic three-dimensional cultures can
also differentiate into alveolar cells. When colonies arising
from cells obtained from 30-day-old ex vivo co-cultures
were exposed to lactogenic stimuli, they expressed the
milk protein β-casein (Figure 2H). Taken together, our
data demonstrate that tri-potent epithelial progenitor cells
can be maintained in our ex vivo co-culture conditions.
Transforming growth factor (TGF)β signaling is active in
mesenchymal cells from co-cultures
Breast epithelial and mesenchymal precursors mutually
constrain their growth and spreading in our ex vivo co-
cultures (Figure 3A). Staining of 40-day-old ex vivo cul-
tures for the proliferation marker Ki67 showed less pro-
liferation in PHBECs and hAMSCs grown as co-cultures
than as monocultures (Figure 3B). Consistently, GSEA
analysis of the gene expression profiles of PHBECs or
hAMSCs sorted by FACS revealed that PHBECs and
hAMSCs grown as monocultures displayed significant
expression of cell-cycle genes. In contrast, PHBECs and
hAMSCs derived from co-cultures expressed neither
cell-cycle genes (Figure 3C-E and see Additional files 6
and 7) nor apoptosis genes (Figure 3F, G).
Hierarchical clustering revealed distinct gene expres-
sion patterns of PHBECs and hAMSCs grown as co-
cultures compared with those grown as monocultures
(Figure 4A). Many genes were specifically downregulatedin co-cultured compared with monocultured PHBECs
(see Additional files 5F and 8, far right). Gene ontology
mining and Ingenuity pathway analysis (IPA) also showed
downregulation of genes involved in cell-cycle regulation
(see Table 1 and Additional files 6 and 9A), further con-
firming that epithelial cells stay quiescent when co-
cultured with mesenchymal cells.
Notably, changes in gene expression were more dra-
matic in co-cultured than in monocultured hAMSCs
(Additional file 10 and Figure 4B right). ECM compo-
nents, chemokines and cytokines were among the most
significantly upregulated genes in co-cultured compared
with monocultured hAMSCs (Figure 4B (right) and
Additional file 10). IPA upstream factor analysis revealed
TNF, IL1β, and TP53 to be inactive, whereas TGFβ1 was
predicted to be active in hAMSCs grown in co-cultures
(Table 2 and Additional file 9B). Downstream targets of
several other components of TGFβ signaling were also
significantly enriched among the genes specific for co-
cultured hAMSC (Table 2).
Inhibin β A (INHBA), a member of the TGFβ family,
was significantly upregulated in hAMSCs from co-
cultures compared with monocultures (Figure 4B and
Additional file 10). We asked whether INHBA contrib-
uted to the upregulation of other hAMSC co-culture
signature genes (Figure 4B right and Additional file 10).
Overexpression of INHBA in hAMSCs increased ex-
pression of integrin alpha 11 (ITGA11), collagen type
XI, alpha 1 (COL11A1), epiphycan (EPYC), and activated
matrix metallopeptidase 13 (MMP13) but not the expres-
sion of sulfatase 1 (SULF1) or TNFSF4 (Figure 4C). To
assess the effects of INHBA overexpression in hAMSCs,
we assembled cultures of PHBECs alone or with either
control or INHBA-overexpressing hAMSCs (hAMSC
INHBA), dissociated the cultures after 30 days, and sub-
jected single cells to colony formation assays. Whereas
epithelial cells from monocultures formed few colonies,
epithelial cells derived from co-cultures of PHBECs and
hAMSCs formed colonies at frequencies of 1.7 ± 0.4%.
Notably, epithelial cells derived from co-cultures of
PHBECs and hAMSC INHBA formed colonies at fre-
quencies of 3.6 ± 0.9% (P = 0.023), indicating that constitu-
tive overexpression of INHBA in hAMSCs increases the
colony formation potential of PHBECs (Figure 4D, E).
Discussion
Maintenance of the proliferation and differentiation po-
tentials of non-immortalized primary human breast cells
in long-term ex vivo cultures is of paramount importance
for modeling and understanding heterotypic interactions
in the normal breast. We have shown that primary epithe-
lial and mesenchymal precursors isolated from normal hu-
man breast assemble heterotypic structures that allow
long-term maintenance of primary breast progenitor cells,
A B
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Figure 4 Transforming growth factor (TGF)β signaling is active in mesenchymal cells from co-cultures and overexpression of inhibin β
A (INHBA) in human adipose tissue-derived mesenchymal stem cells (hAMSCs) increases colony formation potential of epithelial cells.
(A) Heat maps derived from unsupervised hierarchical clustering of gene expression data of hAMSCs (n = 3) and primary human breast epithelial
cells (PHBECs) (n = 3) grown as mono- or co-cultures for 21 to 30 days. Upregulated (red); downregulated (green); average expression (black).
(B) Heat maps representing the top 50 upregulated genes specific for hAMSCs in monoculture (MCS) or co-cultures (CCS) compared with PHBECs
in monocultures (MCE) or co-cultures (CCE) (left) and when compared among themselves (right). Upregulated (red); downregulated (blue);
average expression (white). (C) Immunoblots with control and INHBA-overexpressing hAMSC lysates as indicated. Cells were grown on Primaria
plates for 7 days. (D) Representative phase contrast pictures of colonies formed by single cells from 30-day-old PHBEC monocultures or PHBEC/
hAMSC co-cultures. Co-cultures consisted of either control hAMSC or hAMSC overexpressing INHBA. Scale bar 50 μm. (E) Bar graph showing the
percentage of colonies formed by single cells derived from ex vivo co-cultures of PHBECs and co-cultured with either control hAMSCs or hAMSCs
overexpressing INHBA (INHBA o.e.). Representative pictures of crystal violet stained colonies (below).
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http://breast-cancer-research.com/content/16/3/R60which are able to differentiate into luminal and myoe-
pithelial cells, and into cells that produce a milk protein
upon exposure to lactogenic cues.
We have used a cell culture system consisting of M5
medium, oxygen at 5% and an ECM-coated substratum.
A defined serum-free medium was used because serum
composition varies from lot to lot, contains undefined
components, and influences differentiation [57]. Free ra-
dicals generated by non-physiological oxygen tensions
(approximately 20%) in standard cultures harm primary
cells and compromise their proliferation and differenti-
ation [52,53,67,68]. Moreover, recent evidence indicates
that low oxygen tensions are crucial for the maintenance
of mesenchymal and hematopoietic stem cells [69,70]. In
addition to a low oxygen tension in the incubators,
the M5 medium was enriched with antioxidants to
further protect cells from reactive oxygen species [68].The ECM-coated substratum provides a scaffold for
three-dimensional growth of primary cells, while allowing
nutrient and growth factor diffusion. These conditions
allowed long-term heterotypic ex vivo culture of primary
breast cells, maintaining undifferentiated epithelial and
mesenchymal precursors as well as differentiated luminal
and myoepithelial cells.
Recently, a further elegant study has used human pri-
mary cells and a three-dimensional scaffold to reconsti-
tute a multicellular culture model of human breast tissue
[71]. We reconstituted long-term heterotypic co-cultures
based on freshly isolated differentiation-competent breast
mesenchymal and stromal precursor cells in serum-free,
oxygen-controlled cell culture conditions with a rigid
ECM-coated scaffold. In contrast, Wang et al. made use
of more differentiated human mammary epithelial cells
(HuMECs, Invitrogen) and human mammary fibroblasts
Table 1 IPA upstream factor analysis of genes specifically









BNIP3L Activated 3.05 5.60E-12
TP53 Activated 2.82 8.44E-12
let-7 Activated 2.01 1.12E-10
KDM5B Activated 2.90 7.65E-07
CDKN2A Activated 2.70 1.91E-06
MAPK14 Activated 2.28 5.65E-06
TCF3 Activated 3.32 1.49E-05
CEBPD Activated 2.20 1.25E-04
PTHLH Activated 2.20 1.47E-04
UXT Activated 2.22 1.53E-04
TAZ Activated 2.00 6.60E-04
MAP3K7 Activated 2.30 7.45E-04
SMARCB1 Activated 2.14 1.47E-03
P38 MAPK Activated 2.29 6.01E-03
JUN Activated 2.03 1.85E-02
Vegf Inhibited −2.35 1.70E-09
CCND1 Inhibited −2.24 1.12E-08
MYC Inhibited −4.12 1.20E-08
E2F1 Inhibited −2.89 2.51E-07
TBX2 Inhibited −2.53 8.13E-07
FOXO1 Inhibited −3.56 1.67E-05
MYBL2 Inhibited −2.00 3.49E-03
MYCN Inhibited −2.38 7.17E-03






Tgf β 0.88 9.33E-06
PHBECs, primary human breast epithelial cells; hAMSCs: human adipose
tissue-derived mesenchymal stem cells; IPA: Ingenuity pathway analysis.
Table 2 IPA upstream factor analysis of genes specifically









TGFβ1 Activated 2,580 4,76E-16
SMAD2 Activated 2,204 7,91E-06
SMAD3 Activated 2,138 8,05E-06
NOTCH1 Activated 2,102 3,87E-05
Tgf β Activated 2,241 5,70E-05
MKL1 Activated 2,744 4,28E-04
MKL2 Activated 2,449 2,49E-03
MGEA5 Activated 2,887 6,60E-03
INSIG1 Activated 2,621 9,33E-03
GFI1 Activated 2,236 1,56E-02
TNF Inhibited −2,756 1,52E-15
IL1B Inhibited −2,446 2,96E-09
TP53 Inhibited −2,871 5,83E-08
NFkβ (complex) Inhibited −2,030 1,20E-07
CEBPA Inhibited −2,457 1,66E-06
TP63 Inhibited −2,301 5,32E-06
RELA Inhibited −2,192 5,25E-05
PDGF BB Inhibited −2,883 2,02E-04
MYCN Inhibited −2,440 9,87E-04
ALDH2 Inhibited −2,000 1,17E-03
CHUK Inhibited −2,101 1,39E-03






PHBECs, primary human breast epithelial cells; hAMSCs: human adipose
tissue-derived mesenchymal stem cells; IPA: Ingenuity pathway analysis.
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http://breast-cancer-research.com/content/16/3/R60(HMF, ScienCell) as well as human adipose-derived stem
cells (hASCs, Jeffrey Gimble, Pennington Biomedical Re-
search Center, LA, USA) in silk protein scaffolds and
serum-containing cell culture medium at 20% oxygen
tension. Whereas we aimed to dissect mechanisms in-
volved in stromal epithelial reciprocity by characterizing
changes in stromal and epithelial cells upon heterotypic
co-culture compared to monoculture, Wang et al. as-
sessed response to hormone stimulation in their mul-
ticellular culture system. Hence both studies describe
highly valuable experimental model systems based onhuman primary cells that recapitulate the complexity of
human tissue ex vivo.
It has been proposed that stem/progenitor niche struc-
tures include various cell types and secreted ECM com-
ponents [15,17,72,73]. This concept has been proposed
in rodent and human mammary tissue [8,17,18,56,72]
but the exact characteristics and components of the
niche remain ill-defined. Mesenchymal cells were shown
to contribute to stem cell niches in the hematopoietic
system and the gastrointestinal tract [20,22,74]. Here we
provide evidence that heterotypic cultures of breast pri-
mary epithelial and mesenchymal precursors on coated
meshes maintain their proliferation and differentiation
potentials. We further show that co-cultures of hAMSCs
and PHBECs dramatically increase TGFβ signaling in
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chymal cells in heterotypic co-cultures increases the col-
ony formation capacity of epithelial cells.
The heterotypic cultures of human breast cells de-
scribed here will allow further molecular characterization
of non-immortalized stromal and epithelial cells, and
thereby, identify critical signaling circuits maintaining the
differentiation and proliferation potentials of breast epi-
thelial and mesenchymal precursors. This is particularly
important given the involvement of aberrant differen-
tiation and of deregulated stroma-epithelial crosstalk
in tumorigenesis. In addition, these heterotypic three-
dimensional cultures, together with the possibility to
transduce primary breast epithelial cells with up to
five different transgenes [41], offers a framework for test-
ing the relevance of potential oncogenic events identified
by high-throughput sequencing of breast cancer genomes
[31-33]. Moreover, given that different subtypes of breast
cancer are thought to arise from cells with distinct differ-
entiation states [2,3], the culture conditions described here
should allow development of pathophysiologically relevant
ex vivo breast cancer models to test the ever-increasing
number of targeted therapies in development.
Conclusions
Our results demonstrate that heterotypic culture of
breast primary epithelial and mesenchymal precursors
on coated meshes maintains their proliferation and dif-
ferentiation potential and constrains their growth recip-
rocally. Further, we provide evidence that mesenchymal
INHBA increases the colony formation potential of epi-
thelial cells. This co-culture system will prove useful for
further characterization of the molecular mechanisms
mediating interactions between human normal or neo-
plastic breast epithelial cells and the stroma.
Additional files
Additional file 1: Flow cytometry sorting strategy for the isolation
of different epithelial and mesenchymal cell populations from
freshly dissociated breast tissue organoids. (A) Gate to exclude cell
debris is shown. (B) Gate to exclude duplets. (C) Gate to exclude lineage
positive cells. (D) Gate to exclude dead cells. (E) Gates to sort EpCAM +
and CD49+ EpCAM- epithelial cells plus gate to separate mesenchymal
cells. (F) Gates to sort CD10+ and CD10- mesenchymal cells.
Additional file 2: (A) M5 medium maintains the differentiation and
proliferation potentials of primary luminal epithelial cells.
Representative images of K18- (red) and K14- (green) immunofluorescent
staining of primary human breast epithelial cells (PHBECs) cultured in
MEGM, HMM or M5 medium. Bar graph showing the percentage area
covered by cells (left) and the percentage K18-positive cells (right).
*P <0.01, **P <0.16, ***P <0.002, ****P <0.0002. Scale bars 100 μm. (B)
Luminal and myoepithelial cells when cultured in M5 medium are smaller
than in HMM or MEGM medium. Bar graph (upper) shows the average
size of luminal cells (K18 positive) after 28 days culture in MEGM, HMM or
M5 medium. *P = 4.1E-5, **P = 0.04. Bar graph (lower) shows the average
size of myoepithelial cells (K14 positive) after 28 days culture in MEGM,HMM or M5 medium. *P = 1.7E-8, **P = 0.002. Cell size was measured with
ImageJ [75] software; 30 to 100 cells from three different experiments
were analyzed. (C) Representative image of mammospheres grown in M5
medium and a bar graph showing mammosphere formation frequencies
in M5, MEGM and HMM medium. (D) Representative immunofluorescent
staining of PHBEC colonies after colony formation assays in M5 medium;
antibodies p63 (red), K18 (blue) and K14 (green). Scale bar 100 μm. (E)
Human adipose tissue-derived mesenchymal stem cells (hAMSCs) can be
differentiated into cells expressing adipocyte or osteocyte markers.
Representative images of Oil Red O staining marking lipids in adipocytes
(upper) or osteocyte-specific alkaline phosphatase (AP) staining (lower).
Control conditions: mesenchymal stem cell medium (MSCM); differentiation
conditions: MSCM medium supplemented with adipogenic (upper) or
osteogenic differentiation factors (lower). Scale bars 50 μm. (F) Human
breast mesenchymal and epithelial cells can be infected and tagged with
lentiviruses expressing fluorescent marker proteins. Representative phase-
contrast (upper) and fluorescence (lower) images of PHBECs tagged with
VenusNLS and of hAMSCs expressing red fluorescent protein (DsRed2). Scale
bars 50 μm.
Additional file 3: Mesenchymal- and epithelial-specific genes group
human adipose tissue-derived mesenchymal stem cell (hAMSC) or
primary human breast epithelial cell (PHBEC) samples, respectively.
(A) Pearson correlation heat map matrix of gene expression profiles from
three epithelial and three mesenchymal monocultures grown for 30 days
in ex vivo culture conditions. (B) Heat map with clusters derived from
unsupervised hierarchical clustering of gene expression data of hAMSCs
(n = 3) and PHBECs (n = 3) grown as monocultures on an ECM-coated mesh
for 21 to 30 days. Gene cluster enriched for up regulated mesenchymal
genes (left); gene cluster enriched for upregulated epithelial genes (right).
Upregulated (red); downregulated (green); average expression (black).
Additional file 4: (A, B) Mesenchymal and epithelial genes are
enriched in human adipose tissue-derived mesenchymal stem cells
(hAMSCs) and primary human breast epithelial cells (PHBECs),
respectively. Heat maps representing the top 50 gene set enrichment
analysis (GSEA)-ranked genes specific for monocultures of hAMSCs (left)
(n = 3) and monocultures of PHBECs (right) (n = 3). Upregulated (red);
downregulated (blue); average (white). (C, D) PHBECs preserve their
epithelial phenotype and display molecular characteristics of luminal
progenitor cells when cultured in ex vivo conditions on extracellular
matrix (ECM)-coated meshes for 30 days. (C) GSEA with PHBEC-specific
genes and signatures of EpCAM + epithelial cells and CD10+ myoepithelial
and myofibroblast cells [63]. PHBEC/EpCAM+: Enrichment score (ES) = 0.56,
normalized enrichment score (NES) = 1.96, false discovery rate (FDR) <0.001,
P <0.001; PHBEC/CD10+: ES = −0.76, NES = −2.54, FDR <0.001, P < 0.001 (D).
GSEA with PHBEC-specific genes and signatures of EpCAM+ and CD49f +
luminal progenitor cells and a EpCAM − and CD49f + basal cell population
[64]. PHBEC/EpCAM + CD49f+: ES = 0.66, NES = 2.11, FDR <0.001, P <0.001;
PHBEC/EpCAM− CD49f+: ES = −0.56, NES = −2.29, FDR <0.001, P <0.001 (E).
GSEA with PHBEC-specific genes and signatures of BPEC or HMEC,
respectively [1]. PHBEC/BPEC: ES = 0.56, NES = 1.53, FDR = 0.01, P = 0.006;
PHBEC/HMEC: ES = −0.45, NES = −1.33, FDR = 0.1, P = 0.09. (F, G) hAMSCs
cultured in ex vivo conditions maintain mesenchymal stem cell (MSC) gene
expression profiles. GSEA with hAMSC or PHBEC signatures and MSC
signatures. For Pedemonte et al. [66]: hAMSC: ES = 0.7, NES = 1.38,
FDR = 0.13, P <0.001; PHBEC: ES = −0.7, NES = −1.4, FDR = 0.097, P < 0.001.
For Huang et al. [65]: hAMSC: ES = 0.82, NES = 1.31, FDR = 0.092, P <0.001;
PHBEC: ES = −0.82, NES = −1.3, FDR = 1.116, P <0.001.
Additional file 5: (A) Phase-contrast (upper left) and fluorescence
images of mixed aggregates from primary human breast epithelial
cells (PHBECs) expressing enhanced green fluorescent protein
(EGFP) and h human adipose tissue-derived mesenchymal stem cells
(hAMSCs) expressing red fluorescent protein (DsRed2) maintained in
suspension. Scale bar 300 μm. (B) Epithelial cells maintained as
co-cultures (CCE) are significantly enriched in luminal genes, whereas
epithelial cells maintained in monocultures (SCE) are not. CCE and MCE-
specific genes were identified by comparison (gene set enrichment
analysis (GSEA) analysis of variance (ANOVA)) to each other or to
co-culture stromal cells (CCS). The signatures were compared (GSEA) to
signatures of EpCAM + CD49f − luminal cells [64]. CCE versus CCS:
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http://breast-cancer-research.com/content/16/3/R60enrichment score (ES) = 0.45, normalized enrichment score (NES) = 1.58,
false discovery rate (FDR) <0.005, P <0.005; CCE versus MCE: ES = 0.43,
NES = 1.80, FDR <0.005, P <0.005; MCE versus CCS: ES = 0.29, NES = 0.99,
FDR = 0.47, P = 0.47. (C-E) Confocal images of EpCAM/K18 (C), ECAD
(CDH1)/K18 (D), and K14/K18/ERα stained 40-day-old co-cultures of
PHBECs and hAMSCs grown on an extracellular matrix (ECM)-coated
mesh: 4',6-diamidino-2-phenylindole (DAPI)- (blue) stained nuclei. Scale
bars 40 μm. (F) Epithelial genes are upregulated in PHBECs from
co-cultures (CCE). Heat maps representing the top 50 upregulated genes
specific for PHBECs in monoculture (MCE) or co-cultures (CCE) compared
among themselves (right) or with hAMSCs in monocultures (MCS) or
co-cultures (CCS) (left). Upregulated (red); downregulated (blue); average
(white). (G) Fluorsence-actived cell sorting (FACS) plots of dissociated cells
from 70-day-old co-culture (CC), PHBEC and hAMSC monocultures (MCE,
MCS). Cells were stained with CD49f-FITC, EpCAM-PerCP Cy5.5 and DAPI.
Only viable cells (DAPI−) were analyzed. (H) Mesenchymal precursor cells
are maintained in long-term co-cultures. Images of Oil-Red-O staining
marking lipids in adipocytes (upper) or osteocyte-specific alkaline
phosphatase (AP) staining (lower) after differentiation of FACS-sorted
mesenchymal precursor cells from 60-day-old co-cultures. Control: M5
medium; differentiation conditions: M5 medium supplemented with
adipogenic (upper) or osteogenic differentiation factors (lower). Scale
bars 100 μm.
Additional file 6: Genes involved in cell cycle and cell division are
significantly upregulated in monocultured primary human breast
epithelial cells (PHBECs), whereas co-cultured PHBECs do not
express these genes. Gene Ontology (GO) mining was performed with
significantly upregulated genes in monocultured PHBECs compared to
co-cultured PHBECs. The parent–child union algorithm with Bonferroni
correction (P-value (Adj)) was applied in ontologizer [48]. The most
significant GO terms are shown.
Additional file 7: Genes involved in cell cycle progression and DNA
replication are downregulated in co-cultured primary human breast
epithelial cells (PHBECs). Gene set enrichment analysis (GSEA) was
performed with genes that are upregulated in monocultured PHBECs and
downregulated in co-cultured PHBECs. Most significant Molecular
Signatures Database (MSigDB) gene sets (GS) enriched in monocultured
PHBECs are shown. ES, enrichment score; NES, normalized enrichment
score; NOM P-value, Nominal P-value, statistical significance of the
enrichment score; FDR, false discovery rate (<0.25 is significant).
Additional file 8: Most significantly upregulated and
downregulated genes in primary human breast epithelial cells
(PHBECs) in ex vivo co-cultures. LogFC_CCE-MCE, computed log fold
change of comparison of gene expression levels in PHBECs in co-cultures
(CCE) versus PHBECs in monocultures (MCE) (see Material and methods).
pVal_CCE-MCE, P-value representing significance of comparison.
Additional file 9: Primary human breast epithelial cells (PHBECs) in
heterotypic ex vivo cultures are quiescent and human adipose
tissue-derived mesenchymal stem cells (hAMSCs) show activated
transforming growth factor (TGF)β1 signaling. (A) Downstream
regulated targets of CCND1 and p16 (CDKN2A) in co-culture PHBECs
displayed as networks. (B) Downstream regulated targets of TGFβ1 in
co-culture hAMSCs displayed as networks. Orange shapes, active regulators;
blue shapes, inactive regulators; red-shaded shapes, upregulated targets;
green-shaded shapes, downregulated targets; gray lines, activity not
predictable; yellow lines, activity contradictive.
Additional file 10: Most significantly upregulated and
downregulated genes in human adipose tissue-derived mesenchymal
stem cells (hAMSCs) in ex vivo co-cultures. LogFC_CCS-MCS, computed
log-fold change in comparison of gene expression levels in hAMSCs in
co-cultures (CCS) versus hAMSCs in monocultures (MCS) (see Material
and methods). pVal_CCS-MCS, P-value representing significance of
comparison.
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